Table TDI-4 part (ii). Characteristics of new clients entering treatment: demographics and primary drug at treatment in 2003 or most recent year available. Primary drug type used (percentage of new clients using) and of those, the percentage injecting it

Country

 

Opiates

% inj

Cocaine

% inj

Amphetamines

% inj

Ecstasy

Hallucinogens

% inj

Cannabis

Others

Belgium

(1)

21.0

7.0

5.0

5.0

14.0

3.0

3.0

1.0

0.0

44.0

12.0

Czech Republic

 

15.8

84.3

0.4

0.0

55.0

79.4

0.6

0.4

6.3

23.6

4.2

Denmark

 

28.4

7.1

5.6

0.3

10.3

0.2

2.4

0.0

 

44.1

11.6

Germany

(2)

28.0

 

8.0

 

1.0

 

 

1.0

 

51.0

11.0

Greece

 

84.4

47.4

1.3

0.0

0.0

 

0.6

0.1

0.0

11.7

1.9

Spain

(3)

28.0

20.0

42.0

6.0

1.0

6.0

2.0

0.1

9.0

23.0

3.9

France

(4)

50.3

 

6.9

 

0.3

 

1.8

0.3

 

35.9

4.5

Ireland

(5)

44.6

39.2

2.2

2.3

0.3

0.0

9.8

0.2

0.0

38.0

4.9

Italy

(6)

 

 

 

 

 

 

 

 

 

 

 

Cyprus

 

54.6

84.5

6.9

0.0

0.0

 

5.4

0.0

 

30.0

3.1

Latvia

 

45.9

86.3

0.9

0.0

13.2

57.1

0.0

2.8

0.0

4.4

32.8

Lithuania

 

69.1

 

0.6

 

4.8

 

 

0.0

 

0.3

30.0

Luxembourg

(7)

 

 

   

 

   

 

 

 

 

 

 

Hungary

(8)

 

 

 

 

 

 

 

 

 

 

 

Malta

 

69.7

69.8

7.6

16.7

0.0

 

1.2

0.0

 

21.1

0.4

Netherlands

 

16.0

11.0

41.0

1.0

5.0

1.0

2.0

1.0

0.0

32.0

3.0

Austria

(9)

100.0

100.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Poland

(10)

 

 

 

 

 

 

 

 

 

 

 

Portugal

 

80.9

 

4.9

 

0.1

 

0.6

0.3

 

10.6

2.6

Slovenia

(11)

79.4

99.6

1.0

0.4

0.8

0.0

0.2

0.0

 

18.3

0.3

Slovakia

 

34.9

72.9

0.9

12.5

24.6

29.6

0.7

0.8

14.3

23.8

14.3

Finland

 

19.3

78.0

0.5

0.0

31.8

68.1

1.2

0.4

0.0

38.1

8.7

Sweden

 

15.1

32.9

1.5

0.0

30.7

44.6

1.3

0.1

 

30.0

21.3

United Kingdom

(12)

60.0

40.0

12.0

4.0

4.0

22.0

1.0

0.1

7.0

17.0

5.9

Bulgaria

 

90.6

68.2

1.3

0.0

0.9

0.0

0.0

0.0

 

5.0

2.2

Romania

 

80.0

 

1.0

 

0.0

 

0.0

0.0

 

4.0

15.0

Notes: 

Data were not available for: Estonia, Norway, Turkey. 

(1) Last data available refer to 1999. 

(2) Data on amphetamines include amphetamines and ecstasy.

(3) Last data available refer to 2002.    

(4) Data on treatment demand referred to the annual census on clients in treatment carried out in November 2003. 

(5) Last data available refer to 2002. 

(6) Data on substance of abuse and injecting behaviours are not available. 

(7) Last data available refer to 2002. 

(8) Data on substance of abuse and injecting behaviours are not available. 

(9) Data refer to clients in substitution treatment only; figures for opiates as main drug and injecting use are consequently 100%. 

(10) Last data available refer to 2002. Only data available on first treatment is the total number of cases. 

(11) Data refer only to outpatient treatment centres. 

(12) Data relate to the period from 1 April 2002 to 31 March 2003 for Scotland and Northern Ireland; for England from April 2003 to March 2004; Wales: six months periods ending 30 September 2001 and 31 March 2002 combined.      

Sources:

2004 Reitox national reports - standard table 3

See [Table TDI-1] for details on sources.

Data filter | tditab04b-en.xml